Correlation between BTG3, CASP9 and LRP4 single-nucleotide polymorphisms and susceptibility to papillary thyroid carcinoma

Biomark Med. 2022 May;16(7):537-547. doi: 10.2217/bmm-2021-0711. Epub 2022 Apr 1.

Abstract

Objective: To study the association of BTG3, CASP9 and LRP4 single-nucleotide polymorphisms with susceptibility to papillary thyroid carcinoma (PTC). Methods: The BTG3 rs9977638, CASP9 rs884363 and LRP4 rs898604 genotypes of 175 PTC patients and 175 controls were analyzed. Results: Rs9977638 TC genotype and CC genotype, rs884363 CC genotype and rs898604 GG genotype were related to a lower PTC susceptibility risk (p < 0.01). The risk of PTC susceptibility was higher when carrying BTG3 rs9977638 CC, CASP9 rs884363 AC and LRP4 rs898604 AG at the same time (p < 0.01). Conclusion: Combined BTG3, CASP9 and LRP4 genotype analysis has a certain application value in the diagnosis of PTC.

Keywords: BTG3; CASP9; LRP4; papillary thyroid carcinoma; single-nucleotide polymorphism.

MeSH terms

  • Carcinoma, Papillary / genetics
  • Case-Control Studies
  • Caspase 9* / genetics
  • Cell Cycle Proteins* / genetics
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • LDL-Receptor Related Proteins* / genetics
  • Polymorphism, Single Nucleotide
  • Thyroid Cancer, Papillary* / genetics
  • Thyroid Neoplasms* / genetics
  • Thyroid Neoplasms* / pathology

Substances

  • BTG3 protein, human
  • Cell Cycle Proteins
  • LDL-Receptor Related Proteins
  • LRP4 protein, human
  • CASP9 protein, human
  • Caspase 9